Penn Presbyterian Medical Center is a hospital located in the University City section of West Philadelphia. It was founded by Reverend Ephraim D. Saunders in 1871 and formally joined the University of Pennsylvania Health System in 1995.

During the past decade, Penn Presbyterian Medical Center conducted 95 clinical trials. In the 10-year time frame, 95 clinical trials started and 44 clinical trials were completed, i.e. on average, 46.3% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 18 clinical trials were completed. i.e. 36% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn Presbyterian Medical Center" #1 sponsor was "University of Pennsylvania" with 40 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 10 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored and "Bolton Medical" with 5 trials sponsored. Other sponsors include 87 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn Presbyterian Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator, "Medical University of South Carolina" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator and "University of Pennsylvania" with 5 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Penn Presbyterian Medical Center" are "HIV Infections" (12 trials), "Coronary Artery Disease" (11 trials), "Atrial Fibrillation" (9 trials), "Coronary Disease" (8 trials) and "Traumatic Brain Injury" (7 trials). Many other conditions were trialed in "Penn Presbyterian Medical Center" in a lesser frequency.

Most popular intervention types in "Penn Presbyterian Medical Center" are "Drug" (77 trials), "Device" (42 trials), "Other" (26 trials), "Procedure" (16 trials) and "Behavioral" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Computed Tomography" (4 trials), "Pemetrexed" (4 trials), "Biospecimen Collection" (3 trials) and "Crizotinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Penn Presbyterian Medical Center" are 151 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 55 active trials in "Penn Presbyterian Medical Center". 2 are not yet recruiting, 24 are recruiting, 22 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 88 completed trials in Penn Presbyterian Medical Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Penn Presbyterian Medical Center, 16 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 54 trials that are defined as “Not Applicable".